Blaze Bioscience Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

BabyTech

Industry

Estimated Revenue & Valuation

  • Blaze Bioscience's estimated annual revenue is currently $4.4M per year.(i)
  • Blaze Bioscience's estimated revenue per employee is $128,000

Employee Data

  • Blaze Bioscience has 34 Employees.(i)
  • Blaze Bioscience grew their employee count by -11% last year.

Blaze Bioscience's People

NameTitleEmail/Phone
1
VP Finance and OperationsReveal Email/Phone
2
EVP, Research & DevelopmentReveal Email/Phone
3
VP, CDP TherapeuticsReveal Email/Phone
4
VP Research and Project ManagementReveal Email/Phone
5
SVP Legal and Intellectual PropertyReveal Email/Phone
6
SVP, Research & Translational SciencesReveal Email/Phone
7
sVP Process Development & ManufacturingReveal Email/Phone
8
VP Clinical ResearchReveal Email/Phone
9
SVP Finance & OperationsReveal Email/Phone
10
Associate Director, Program ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M34-11%N/AN/A
#2
$294.5M0N/A$352MN/A
#3
$2.8M25-22%N/AN/A
#4
$12.2M769%N/AN/A
#5
$1.3M148%N/AN/A
#6
$15.7M987%N/AN/A
Add Company

What Is Blaze Bioscience?

For years, surgeons have been searching for better intraoperative tools to more effectively treat brain cancer. When removing tumors, the ability to precisely identify them is of paramount importance. If too little tissue is removed, cancer cells are left behind to grow and spread. If too much tissue is removed, the patient may experience significant disabilities, including paralysis. Despite advances in intraoperative monitoring and image guidance, postoperative scans sometimes reveal bulky residual tumor that may have been resected safely if surgeons had improved tools to distinguish tumor tissue from normal brain. A team of neurosurgeons, engineers and biologists at the Fred Hutchinson Cancer Research Center and Seattle Children's Hospital Research Institute, led by Dr. Jim Olson, has created a technology that illuminates cancer cells distinguishing tumors from healthy tissue. Tumor Paint technology will enable surgeons to see tumors "live" during surgery giving them a better chance of removing all of the cancerous cells without injuring surrounding healthy tissue.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$4.4M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Blaze Bioscience News

2022-04-20 - Form DEF 14A CarParts.com, Inc. For: May 25

Ms. Liu is a board member for both Blaze Technology and Nanoly Bioscience. Neither of these companies have securities listed on a national...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M3417%N/A
#2
$7M34-6%N/A
#3
$6000M34N/AN/A
#4
$3.9M3410%N/A
#5
$5.3M343%N/A